Effects of intrahepatic bone-derived mesenchymal stem cells autotransplantation on the diabetic Beagle dogs

Journal of Surgical Research

Volumn 168, Issue 2, 2011, Pages 213-223

  Zhu, Shajun ^a   Lu, Yuhua ^a   Zhu, Jianwei ^a   Xu, Jian ^b   Huang, Hua ^a   Zhu, Mingyan ^a   Chen, Yuquan ^a   Zhou, Yuan ^a   Fan, Xiangjun ^a   Wang, Zhiwei ^a  

^a NANTONG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

autotransplantation; bone derived mesenchymal stem cells; diabetes; gene therapy; insulin

Indexed keywords

C PEPTIDE; EPIDERMAL GROWTH FACTOR; GLUCOSE; INSULIN; RETROVIRUS VECTOR;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; BEAGLE CANINE MESENCHYMAL STEM CELL; BODY WEIGHT; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; EXPERIMENTAL DOG; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAHEPATIC CELL TRANSPLANTATION; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; C-PEPTIDE; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; DOGS; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; GENETIC VECTORS; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RECOMBINANT PROTEINS; RETROVIRIDAE; TRANSPLANTATION, AUTOLOGOUS;

EID: 79955838049     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.10.008     Document Type: Article

References (42)

1. Hornum L, Markholst H. New autoimmune genes and the pathogenesis of type 1 diabetes. Curr Diab Rep 2004;4:135.
2. Gillespie KM. Type 1 diabetes: Pathogenesis and prevention. Can Med Assoc J 2006;175:165.
3. Roep BO. The role of T-cells in the pathogenesis of type 1 diabetes: From cause to cure. Diabetologia 2003;46:305.
4. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: Pathogenesis and treatment. Lancet 2008;371:2153.
5. Steffes MW, Sibley S, Jackson M, et al. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 2003;26:832.
6. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid- free immunosuppressive regimen. N Engl J Med 2000; 343:230.
7. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005;54:2060.
8. Coppelli A, Giannarelli R, Vistoli F, et al. The beneficial effects of pancreas transplant alone on diabetic nephropathy. Diabetes Care 2005;28:1366.
9. Roche E, Santana A, Vicente-salar N, et al. From stem cells to insulin- producing cells: Towards a bioartificial endocrine pancreas. Panminerva Med 2005;47:39.
10. Shah R, Jindal RM. Reversal of diabetes in the rat by injection of hematopoietic stem cells infected with recombinant adeno-associated virus containing the preproinsulin II gene. Pancreatology 2003;3:422.
11. He CX, Shi D, Wu WJ, et al. Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration. World J Gastroenterol 2004;10:567.
12. Porada CD, Zanjani ED, Almeida-Porad G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther 2006;1:365.
13. Kumar S, Chanda D, Ponnazhagan S. Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 2008; 15:711.
14. Picinich SC, Mishra PJ, Mishra PJ, et al. The therapeutic potential of mesenchymal stem cells. Cell- and tissue-based therapy. Expert Opin Biol Ther 2007;7:965.
15. Kassem M, Kristiansen M, Abdallah BM. Mesenchymal stem cells: Cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 2004;95:209.
16. Lu Y, Wang Z, Zhu M. Human bone marrow mesenchymal stem cells transfected with human insulin genes can secrete insulin stably. Ann Clin Lab Sci 2006;36:127.
17. Xu J, Lu YH, Ding F, et al. Reversal of diabetes in mice by intrahepatic injection of bone derived GFP-murine mesenchymal stem cells infected with recombinant retrovirus carrying human insulin gene. World J Surg 2007;31:1872.
18. Gao Z, Golob J, Tanavde VM, et al. High levels of transgene expression following transduction of long-term NOD/ SCID-repopulating human cells with a modified lentiviral vector. Stem Cells 2001;19:247.
19. Pannell D, Osborne CS, Yao S, et al. Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J 2000;19:5884.
20. Hawley RG. Progress toward vector design for hematopoietic stem cell gene therapy. Curr Gene Ther 2001;1:1.
21. Adam MA, Ramesh N, Miller AD, et al. Internal initiation of translation in retroviral vectors carrying picornavirus 5% nontranslated regions. J Virol 1991;65:4985.
22. Mountford PS, Smith AG. Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis. Trends Genet 1995; 11:179.
23. Kieft JS, Costantino DA, Filbin ME, et al. Structural methods for studying IRES function. Methods Enzymol 2007;430:333.
24. Pfingsten JS, Costantino DA, Kieft JS. Structural basis for ribosome recruitment and manipulation by a viral IRES RNA. Science 2006;314:1450.
25. Kan Z, Liu TJ. Video microscopy of tumor metastasis: Using the green fluorescent protein (GFP) gene as a cancer-cell-labeling system. Clin Exp Metastasis 1999;17:49.
26. Lin Y, Chen X, Yan Z, et al. Multilineage differentiation of adipose- derived stromal cells from GFP transgenic mice. Mol Cell Biochem 2006;285:69.
27. Ikawa M, Yamada S, Nakanishi T, et al. Green fluorescent protein (GFP) as a vitalmarker inmammals.Curr Top Dev Biol 1999;44:1.
28. Park YM, Woo S, Lee GT, et al. Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague- Dawley rats. J Gene Med 2005;7:621.
29. Ostrander EA, Giniger E. Semper fidelis: What man's best friend can teach us about human biology and disease. Am J Hum Genet 1997;61:475.
30. Starkey MP, Scase TJ, Mellersh CS, et al. Dogs really are man's best friend-canine genomics has applications in veterinary and human medicine. Brief Funct Genomic Proteomic 2005;4:112.
31. Salis AI, Peterson RG, Stecker MS, et al. Suprarenal Intra-arterial infusion of alloxan and streptozotocin during balloon occlusion of the juxtarenal abdominal aorta: A simple technique for inducing diabetes mellitus in canines with reduced mortality. Acad Radiol 2001;8:473.
32. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002;51:2148.
33. Madsen OD, Jensen J, Blume N, et al. Pancreatic development and maturation of the islet B cell. Studies of pluripotent islet cultures. Eur J Biochem 1996;242:435.
34. Gannon M, Gamer LW, Wright CV. Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdx1. Dev Biol 2001;238:1851.
35. Ashizawa S, Brunicardi FC, Wang XP. PDX-1 and the pancreas. Pancreas 2004;28:109.
36. Itkin-Ansari P, Marcora E, Geron I, et al. NeuroD1 in the endocrine pancreas: localization and dual function as an activator and repressor. Dev Dyn 2005;233:946.
37. Wang S, Hecksher-Sorensen J, Xu Y, et al. Myt1 and Ngn3 form a feed-forward expression loop to promote endocrine islet cell differentiation. Dev Biol 2008;317:531.
38. Greenwood AL, Li S, Jones K, et al. Notch signaling reveals developmental plasticity of Pax4(+) pancreatic endocrine progenitors and shunts them to a duct fate. Mech Dev 2007;124:97.
39. Thorens B. GLUT2 in pancreatic and extra-pancreatic glucodetection. Mol Membr Biol 2001;18:265.
40. Karnieli O, Izhar-Prato Y, Bulvik S, et al. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 2007;25:2837.
41. Zalzman M, Gupta S, Giri RK, et al. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc Natl Acad Sci USA 2003;100:7253.
42. Lin HT, Kao CL, Lee KH, et al. Enhancement of insulin-producing cell differentiation from embryonic stem cells using pax4-nucleofection method. World J Gastroenterol 2007; 13:1672.